Krsnaa Diagnostics DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.78×	0.78×	0.76×	0.81×	0.77×
	1.03×	1.07×	1.01×	1.00×	1.17×
	14.9%	15.7%	14.2%	11.2%	14.1%
	0.50×	0.50×	0.58×	0.60×	0.55×
	1.86×	1.86×	1.45×	1.45×	1.23×
	11.1%	12.2%	9.1%	8.0%	8.6%
	10.9%	10.9%	9.2%	7.3%	8.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

KRSNAA₹497.95

Krsnaa Diagnostics Limited

· Pharma & Health

₹ CrorePeersSURAKSHA HEALTHX NEPHROPLUS 3BBLACKBIOMcap ₹1,615 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.77	0.81	0.76	0.78	0.78
Interest Burden (Pretax/EBIT) ×	1.17	1.00	1.01	1.07	1.03
EBIT Margin %	14.07	11.25	14.20	15.71	14.92
Asset Turnover ×	0.55	0.60	0.58	0.50	0.50
Financial Leverage (Assets/Equity) ×	1.23	1.45	1.45	1.86	1.86
ROE (5-step product, year-end total equity) %	8.64	7.96	9.11	12.21	11.12
ROE (owners' profit / average owners' equity) %	8.73	7.34	9.17	10.89	10.89

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.